Clostridium difficile infections: An unexpected re-emergence;Infections à Clostridium difficile : une ré-émergence inattendue

Pathologie Biologie

Volumn 56, Issue 1, 2008, Pages 6-9

  Barbut, F ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Antibiotics; Colitis; Diarrhea; Nosocomial; Outbreak; PCR ribotype 027 ; Spores; Toxin

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; CLOSTRIDIUM DIFFICILE; EDITORIAL; HUMAN; NONHUMAN; STAPHYLOCOCCUS AUREUS;

AGED; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; HUMANS; QUEBEC;

EID: 39149111583     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.09.017     Document Type: Editorial

References (46)

1. Beaugerie L., Flahault A., Barbut F., Atlan P., Lalande V., Cousin P., et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 17 7 (2003) 905-912
2. Tedesco F.J., Barton R.W., and Alpers D.H. Clindamycin-associated colitis. A prospective study. Ann Intern Med 81 4 (1974) 429-433
3. Bartlett J.G., Chang T., Taylor N.S., and Onderdonk A.B. Colitis induced by Clostridium difficile. Rev Infect Dis 1 2 (1979) 370-378
4. Larson H.E., Price A.B., Honour P., and Borriello S.P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1 8073 (1978) 1063-1066
5. Banno Y., Kobayashi T., Kono H., Watanabe K., Ueno K., and Nozawa Y. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis 6 Suppl 1 (1984) S11-S20
6. Barbut F., and Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7 8 (2001) 405-410
7. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145 10 (2006) 758-764
8. Lyerly D.M., Krivan H.C., and Wilkins T.D. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1 1 (1988) 1-18
9. Morris J.B., Zollinger Jr. R.M., and Stellato T.A. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg 160 5 (1990) 535-539
10. Olson M.M., Shanholtzer C.J., Lee Jr. J.T., and Gerding D.N. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 15 6 (1994) 371-381
11. Kelly C.P., Pothoulakis C., and LaMont J.T. Clostridium difficile colitis. N Engl J Med 330 4 (1994) 257-262
12. Rupnik M., Dupuy B., Fairweather N.F., Gerding D.N., Johnson S., Just I., et al. Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54 (2005) 113-117
13. Savidge T.C., Pan W.H., Newman P., O'Brien M., Anton P.M., and Pothoulakis C. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 125 2 (2003) 413-420
14. McFarland L.V., Mulligan M.E., Kwok R.Y., and Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320 4 (1989) 204-210
15. Barbut F., Gotty S., Magne S., Bernardon S., Burghoffer B., Ribadeau-Dumas F., et al. Clostridium difficile : hygiène des mains et environnement. Hygiènes 6 (2003) 449-455
16. Réseau d'Alerte d'Investigation et de Surveillance des Infections Nosocomiales. Conduite à tenir : diagnostic, surveillance, investigation, prévention et contrôle des infections à Clostridium difficile: Institut de Veille Sanitaire; 2006.
17. Svenungsson B., Burman L.G., Jalakas-Pornull K., Lagergren A., Struwe J., and Akerlund T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J Clin Microbiol 41 9 (2003) 4031-4037
18. Barbut F., Gariazzo B., Bonne L., Lalande V., Burghoffer B., Luiuz R., et al. Clinical Features of Clostridium difficile-associated infections and Molecular Characterization of Strains: Results of a Retrospective Study, 2000-2004. Infect Control Hosp Epidemiol 28 2 (2007) 131-139
19. Pepin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Cmaj 171 5 (2004) 466-472
20. Loo V.G., Libman M.D., Miller M.A., Bourgault A.M., Frenette C.H., Kelly M., et al. Clostridium difficile: a formidable foe. Cmaj 171 1 (2004) 47-48
21. Miller M.A., Hyland M., Ofner-Agostini M., Gourdeau M., and Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 23 3 (2002) 137-140
22. McDonald L.C., Owings M., and Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 12 3 (2006) 409-415
23. Polk R.E., Oinonen M., and Pakyz A. Epidemic Clostridium difficile. N Engl J Med 354 11 (2006) 1199-1203 author reply -203
24. Pepin J., Valiquette L., and Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Cmaj 173 9 (2005) 1037-1042
25. Musher D.M., Aslam S., Logan N., Nallacheru S., Bhaila I., Borchert F., et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40 11 (2005) 1586-1590
26. Muto C.A., Pokrywka M., Shutt K., Mendelsohn A.B., Nouri K., Posey K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26 3 (2005) 273-280
27. Pepin J., Alary M.E., Valiquette L., Raiche E., Ruel J., Fulop K., et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40 11 (2005) 1591-1597
28. McDonald L.C., Killgore G.E., Thompson A., Owens Jr. R.C., Kazakova S.V., Sambol S.P., et al. An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
29. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 9491 (2005) 1079-1084
30. MacCannell D.R., Louie T.J., Gregson D.B., Laverdiere M., Labbe A.C., Laing F., et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol 44 6 (2006) 2147-2152
31. Bourgault A.M., Lamothe F., Loo V.G., and Poirier L. In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Quebec, Canada. Antimicrob Agents Chemother 50 10 (2006) 3473-3475
32. Hubert B., Loo V.G., Bourgault A.M., Poirier L., Dascal A., Fortin E., et al. A Portrait of the Geographic Disseminationof the Clostridium difficile North American Pulsed-Field Type 1 Strain and the Epidemiology of C. difficile-Associated Disease in Quebec. Clin Infect Dis 44 2 (2007) 238-244
33. Smith A. Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US. Euro Surveill 2005;10(6):E050630 2.
34. Kuijper E.J., Van den Berg R.J., Debast S., Visser C.E., Veenendaal D., Troelstra A., et al. Clostridium difficile ribotype 027, toxinotype III, The Netherlands. Emerging Infectious Diseases 12 5 (2006) 827-830
35. Joseph R, Demeyer D, Vanrenterghem D, van den Berg R, Kuijper E, Delmee M. First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill 2005;10(10):E051020 4.
36. Tachon M, Cattoen C, Blanckaert K, Poujol I, Carbonne A, Barbut F et al. First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. Euro Surveill 2006;11(5):E060504 1.
37. Boyce J.M., Ligi C., Kohan C., Dumigan D., and Havill N.L. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 27 5 (2006) 479-483
38. Gordin F.M., Schultz M.E., Huber R.A., and Gill J.A. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol 26 7 (2005) 650-653
39. Pepin J., Saheb N., Coulombe M.A., Alary M.E., Corriveau M.P., Authier S., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 9 (2005) 1254-1260
40. CDC. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005;54(47):1201-5.
41. Spigaglia P., and Mastrantonio P. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53 Pt 11 (2004) 1129-1136
42. Barbut F., Decre D., Lalande V., Burghoffer B., Noussair L., Gigandon A., et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54 Pt 2 (2005) 181-185
43. Arroyo L.G., Stampfli H.R., and Weese J.S. Potential role of Clostridium difficile as a cause of duodenitis-proximal jejunitis in horses. J Med Microbiol 55 Pt 5 (2006) 605-608
44. Rodriguez-Palacios A., Stampfli H.R., Duffield T., et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 12 11 (2006) 1730-1736
45. Keel K., Brazier J.S., Post K.W., Weese S., and Songer J.G. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45 6 (2007) 1963-1964
46. Rodriguez-Palacios A., Staempfli H.R., Duffield T., and Weese J.S. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 13 3 (2007) 485-487